para que es el tirzepatide Cómo actúa tirzepatida, la nueva molécula dual e inyectable tratamiento de la obesidad y la diabetes disponible en Argentina El medicamento para la diabetes

Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose

Regardless of which telehealth platform you ultimately choose, ask these questions: Where is my medication being compounded

2021;10:e66079

Another way to look at this is how many people needed to be treated to prevent a premature cardiovascular or diabetes-related death

O.Coimbra-CamposL

Lane, M.M., Gamage, E., Du, S., Ashtree, D.N., McGuinness, A.J., Gauci, S., Barr, P., et al